Immunological signatures from irradiated cancer-associated fibroblasts

被引:1
|
作者
Berzaghi, Rodrigo [1 ]
Gundersen, Kristian [1 ]
Pedersen, Brede Dille [2 ]
Utne, Amalie [2 ]
Yang, Nannan [3 ]
Hellevik, Turid [2 ]
Martinez-Zubiaurre, Inigo [1 ]
机构
[1] UiT Arctic Univ Norway, Fac Hlth Sci, Dept Clin Med, Tromso, Norway
[2] Univ Hosp North Norway, Dept Radiat Oncol, Tromso, Norway
[3] UiT Arctic Univ Norway, Fac Hlth Sci, Dept Community Med, Tromso, Norway
来源
FRONTIERS IN IMMUNOLOGY | 2024年 / 15卷
关键词
cancer-associated fibroblasts; CAFs; immunosuppression; ionizing radiation; radiotherapy; non-small cell lung cancer; NSCLC; tumor microenvironment; NF-KAPPA-B; RADIATION-THERAPY; ABLATIVE RADIOTHERAPY; EXPRESSION; INHIBITION; RESISTANCE; HALLMARKS; IMMUNITY; PATHWAY; SYSTEM;
D O I
10.3389/fimmu.2024.1433237
中图分类号
R392 [医学免疫学]; Q939.91 [免疫学];
学科分类号
100102 ;
摘要
Introduction Cancer-associated fibroblasts (CAFs) are abundant and influential elements of the tumor microenvironment (TME), giving support to tumor development in multiple ways. Among other mechanisms, CAFs are important regulators of immunological processes occurring in tumors. However, CAF-mediated tumor immunomodulation in the context of radiotherapy remains poorly understood. In this study, we explore effects of radiation on CAF-derived immunoregulatory signals to the TME.Methods Primary CAF cultures were established from freshly collected human NSCLC lung tumors. CAFs were exposed to single-high or fractionated radiation regimens (1x18Gy or 3x6Gy), and the expression of different immunoregulatory cell-associated and secreted signaling molecules was analyzed 48h and 6 days after initiation of treatment. Analyses included quantitative measurements of released damage-associated molecular patterns (DAMPs), interferon (IFN) type I responses, expression of immune regulatory receptors, and secretion of soluble cytokines, chemokines, and growth factors. CAFs are able to survive ablative radiation regimens, however they enter into a stage of premature cell senescence.Results Our data show that CAFs avoid apoptosis and do not contribute by release of DAMPs or IFN-I secretion to radiation-mediated tumor immunoregulation. Furthermore, the secretion of relevant immunoregulatory cytokines and growth factors including TGF-beta, IL-6, IL-10, TNF alpha, IL-1 beta, VEGF, CXCL12, and CXCL10 remain comparable between non-irradiated and radiation-induced senescent CAFs. Importantly, radiation exposure modifies the cell surface expression of some key immunoregulatory receptors, including upregulation of CD73 and CD276.Discussion Our data suggest that CAFs do not participate in the release of danger signals or IFN-I secretion following radiotherapy. The immune phenotype of CAFs and radiation-induced senescent CAFs is similar, however, the observed elevation of some cell surface immunological receptors on irradiated CAFs could contribute to the establishment of an enhanced immunosuppressive TME after radiotherapy.
引用
收藏
页数:14
相关论文
共 50 条
  • [41] IMMUNOMODULATORY PROPERTIES OF CANCER-ASSOCIATED FIBROBLASTS
    Gorch, L.
    Hellevik, T.
    Stuge, T. B.
    Martinez-Zubiaurre, I.
    ANTICANCER RESEARCH, 2014, 34 (10) : 6050 - 6050
  • [42] Cancer-associated fibroblasts—heroes or villains?
    Krystyna A. Gieniec
    Lisa M. Butler
    Daniel L. Worthley
    Susan L. Woods
    British Journal of Cancer, 2019, 121 : 293 - 302
  • [43] Cancer-associated fibroblasts in intrahepatic cholangiocarcinoma
    Sirica, Alphonse E.
    Campbell, Deanna J.
    Dumur, Catherine I.
    CURRENT OPINION IN GASTROENTEROLOGY, 2011, 27 (03) : 276 - 284
  • [44] Cancer-Associated Fibroblasts: Understanding Their Heterogeneity
    Louault, Kevin
    Li, Rong-Rong
    DeClerck, Yves A.
    CANCERS, 2020, 12 (11) : 1 - 28
  • [45] The cancer-associated fibroblasts and drug resistance
    Li, X. -Y.
    Hu, S. -Q.
    Xiao, L.
    EUROPEAN REVIEW FOR MEDICAL AND PHARMACOLOGICAL SCIENCES, 2015, 19 (11) : 2112 - 2119
  • [46] Cancer-Associated Fibroblasts: From Spectators to Protagonists in Pancreatic Cancer Progression
    Mucciolo, Gianluca
    Li, Wenlong
    Biffi, Giulia
    CANCER RESEARCH, 2024, 84 (18) : 2938 - 2940
  • [47] Antigen Presentation By Cancer-Associated Fibroblasts
    Kina, Eralda
    Cote, Caroline
    Larouche, Jean-David
    Durette, Chantal
    Lanoix, Joel
    Bonneil, Eric
    Laverdure, Jean-Philippe
    Lavallee, Gabriel Ouellet
    Buchanan, Margaret
    Aguilar, Adriana
    Mechta-Grigoriou, Fatima
    Thibault, Pierre
    Basik, Mark
    Perreault, Claude
    CANCER IMMUNOLOGY RESEARCH, 2024, 12 (10)
  • [48] Cancer-Associated Fibroblasts in Intrahepatic Cholangiocarcinoma
    Affo, Silvia
    Sererols-Vinas, Laura
    Garcia-Vicien, Gemma
    Cadamuro, Massimiliano
    Chakraborty, Sanjukta
    Sirica, Alphonse E.
    AMERICAN JOURNAL OF PATHOLOGY, 2025, 195 (03): : 378 - 396
  • [49] MicroRNA regulation in cancer-associated fibroblasts
    Olga Aprelikova
    Jeffrey E. Green
    Cancer Immunology, Immunotherapy, 2012, 61 : 231 - 237
  • [50] Cancer-associated fibroblasts in pancreatic adenocarcinoma
    Pan, Boju
    Liao, Quan
    Niu, Zheyu
    Zhou, Li
    Zhao, Yupei
    FUTURE ONCOLOGY, 2015, 11 (18) : 2603 - 2610